{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:25:23Z","timestamp":1769610323385,"version":"3.49.0"},"reference-count":27,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>This study examined national\u2010level trends, characteristics, and perioperative outcomes of women who had intra\u2010arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum (PAS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>This was a population\u2010based retrospective observational study that queried the National Inpatient Sample from October 2015 to December 2018. Study population was women who underwent hysterectomy at cesarean delivery for PAS (<jats:italic>n\u00a0<\/jats:italic>=\u00a06440 in 806 centers). Exposure allocation was the use of intra\u2010arterial balloon occlusion. Main outcome measures were (a) characteristics associated with intra\u2010arterial balloon occlusion use, and (b) perioperative outcome including hemorrhage, blood transfusion, coagulopathy, shock, urinary tract injury, intra\u2010arterial balloon occlusion\u2010related complication (arterial injury, arterial thrombosis, and lower extremities ischemia), and death, assessed in multivariable analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Intra\u2010arterial balloon occlusion was used in 420 (6.5%) women in 64 (7.9%) centers. Utilization of intra\u2010arterial balloon occlusion during cesarean hysterectomy for placenta accreta decreased significantly over time (from 6.3% to 3.1%, <jats:italic>p\u00a0<\/jats:italic>&lt;\u00a00.001), but not in placenta increta (from 12.8% to 9.3%, <jats:italic>p\u00a0<\/jats:italic>=\u00a00.204) or placenta percreta (from 21.3% to 17.5%, <jats:italic>p\u00a0<\/jats:italic>=\u00a00.344). In a multivariable analysis, patient factors (younger age, earlier year, obesity, diabetes mellitus), pregnancy factors (placenta increta\/percreta, previous cesarean delivery, placenta previa, and early gestational age), and facility factors (large bed capacity, urban teaching status, and Northeast\/West regions) represented the independent characteristics for using the intra\u2010arterial balloon occlusion (all, <jats:italic>p\u00a0<\/jats:italic>&lt;\u00a00.05). In a classification\u2010tree model, the absolute difference in intra\u2010arterial balloon occlusion use among 18 utilization patterns was 48% (range, 0%\u201348%). In perioperative outcome analysis, women who received intra\u2010arterial balloon occlusion were more likely to have coagulopathy (adjusted odds ratio [aOR] 3.43) and arterial thrombosis (aOR 9.82) in placenta accreta, but less likely to have hemorrhage (aOR 0.25) in placenta increta, and blood transfusion (aOR 0.60) and urinary tract injury (aOR 0.28) in placenta percreta compared with those who did not (all, <jats:italic>p\u00a0<\/jats:italic>&lt;\u00a00.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is a wide range in the utilization of intra\u2010arterial balloon occlusion at cesarean hysterectomy for PAS based on patient, pregnancy, and facility factors, which implies that there is a lack of universal practice guidelines in this surgical procedure. Whether the use of intra\u2010arterial balloon occlusion in the severe forms of PAS improves surgical outcome merits further investigation.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aogs.14266","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:20:02Z","timestamp":1633846802000},"page":"2234-2243","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Utilizations and outcomes of intra\u2010arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum"],"prefix":"10.1111","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of Southern California Los Angeles CA USA"},{"name":"Norris Comprehensive Cancer Center University of Southern California Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of Southern California Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Vestal","sequence":"additional","affiliation":[{"name":"Keck School of Medicine University of Southern California Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rauvynne N.","family":"Sangara","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of Southern California Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of Southern California Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Division of Acute Care Surgery Department of Surgery University of Southern California Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Faculty of Medicine University of Freiburg Freiburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph G.","family":"Ouzounian","sequence":"additional","affiliation":[{"name":"Division of Maternal\u2010Fetal Medicine Department of Obstetrics and Gynecology University of Southern California Los Angeles CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1709324"},{"issue":"384","key":"e_1_2_10_3_1","first-page":"e381","article-title":"Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor?","volume":"213","author":"Creanga AA","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.09.042"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.02.054"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002983"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.01.044"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12763"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5527-7"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003792"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001113"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-005-0023-2"},{"issue":"402","key":"e_1_2_10_13_1","first-page":"e401","article-title":"Case\u2010control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta","volume":"197","author":"Shrivastava V","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2014.05.007"},{"key":"e_1_2_10_15_1","unstructured":"National Inpatient Sample (NIS).Healthcare Cost and Utilization Project (HCUP). 2001\u20102015. Agency for Healthcare Research and Quality. Rockville MD. Accessed May 19 2021.www.hcup\u2010us.ahrq.gov\/nisoverview.jsp"},{"key":"e_1_2_10_16_1","unstructured":"SoniA FingarKR ReidLD.Obstetric Delivery Inpatient Stays Involving Substance Use Disorders and Related Clinical Outcomes 2016. HCUP Statistical Brief #254. Rockville MD October 2019. Accessed August 17 2021.https:\/\/www.hcup\u2010us.ahrq.gov\/reports\/statbriefs\/sb254\u2010Delivery\u2010Hospitalizations\u2010Substance\u2010Use\u2010Clinical\u2010Outcomes\u20102016.jsp"},{"key":"e_1_2_10_17_1","unstructured":"Centers for Disease Control and Prevention.How Does CDC Identify Severe Maternal Morbidity?Accessed May 19 2021.https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/smm\/severe\u2010morbidity\u2010ICD.htm"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.04.233"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16179"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14034"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw040"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00619-0"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6782"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0600"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0528"},{"key":"e_1_2_10_26_1","unstructured":"NIH.Consensus Development Conference on Vaginal Birth After Cesarean: New InsightsAccessed May 19 2021.https:\/\/consensus.nih.gov\/2010\/vbacstatement.htm"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.04.049"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.09.017"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.14266","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aogs.14266","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.14266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:25:31Z","timestamp":1693196731000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/aogs.14266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1111\/aogs.14266"],"URL":"https:\/\/doi.org\/10.1111\/aogs.14266","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"assertion":[{"value":"2021-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}